Recent review articles about melanoma (InTextoResearch)


InTextoResearch, scientific information agency


InTextoResearch informs on the most recent review articles about
melanoma:

Therapeutic vaccination for the treatment of malignant melanoma.
Walden P.
Recent Results Cancer Res. 2007;176:219-27.

Antigen-specific cancer vaccines.
Keilholz U.
Recent Results Cancer Res. 2007;176:213-8.

Angiogenesis and metastasis inhibitors for the treatment of malignant
melanoma.
Abe R, Fujita Y, Yamagishi S.
Mini Rev Med Chem. 2007 Jun;7(6):649-61.

Malignant melanoma of the sinonasal mucosa: two case reports and a
review.
Sanderson AR, Gaylis B.
Ear Nose Throat J. 2007 May;86(5):287-9, 294.

Surgical therapy of cutaneous melanoma.
Blazer DG 3rd, Sondak VK, Sabel MS.
Semin Oncol. 2007 Jun;34(3):270-80.

Oblimersen in the treatment of metastatic melanoma.
Tarhini AA, Kirkwood JM.
Future Oncol. 2007 Jun;3(3):263-71.

Melanoma invasion - current knowledge and future directions.
Gaggioli C, Sahai E.
Pigment Cell Res. 2007 Jun;20(3):161-72.

Specific amino acid dependency regulates the cellular behavior of
melanoma.
Fu YM, Meadows GG.
J Nutr. 2007 Jun;137(6 Suppl 1):1591S-1596S.

Diagnosis and treatment of cutaneous melanoma: state of the art 2006.
Garbe C, Eigentler TK.
Melanoma Res. 2007 Apr;17(2):117-27.

Novel inhibitors in the treatment of metastatic melanoma.
Kalinsky K, Haluska FG.
Expert Rev Anticancer Ther. 2007 May;7(5):715-24.

New approaches in metastatic melanoma: biological and molecular
targeted therapies.
Lejeune FJ, Rimoldi D, Speiser D.
Expert Rev Anticancer Ther. 2007 May;7(5):701-13.

Alpha-melanocyte stimulating hormone peptide-targeted melanoma
imaging.
Miao Y, Quinn TP.
Front Biosci. 2007 May 1;12:4514-24.

Intradural extramedullary primary malignant melanoma radiographically
mimicking a neurofibroma.
Kanatas AN, Bullock MD, Pal D, Chakrabarty A, Chumas P.
Br J Neurosurg. 2007 Feb;21(1):39-40.

Angiotropic melanoma and extravascular migratory metastasis: a review.
Lugassy C, Barnhill RL.
Adv Anat Pathol. 2007 May;14(3):195-201.

Toward a molecular classification of melanoma.
Fecher LA, Cummings SD, Keefe MJ, Alani RM.
J Clin Oncol. 2007 Apr 20;25(12):1606-20.

Sentinel lymph node molecular ultrastaging in patients with melanoma:
a systematic review and meta-analysis of prognosis.
Mocellin S, Hoon DS, Pilati P, Rossi CR, Nitti D.
J Clin Oncol. 2007 Apr 20;25(12):1588-95.

Melanoma genomics reveals signatures of sensitivity to bio- and
targeted therapies.
Timar J, Meszaros L, Ladanyi A, Puskas LG, Raso E.
Cell Immunol. 2006 Dec;244(2):154-7.

Proteomics in uveal melanoma research: opportunities and challenges in
biomarker discovery.
Pardo M, Dwek RA, Zitzmann N.
Expert Rev Proteomics. 2007 Apr;4(2):273-86.

Malignant melanoma in the 21st century, part 2: staging, prognosis,
and treatment.
Markovic SN, Erickson LA, Rao RD, Weenig RH, Pockaj BA, Bardia A,
Vachon CM, Schild SE, McWilliams RR, Hand JL, Laman SD, Kottschade LA,
Maples WJ, Pittelkow MR, Pulido JS, Cameron JD, Creagan ET; Melanoma
Study Group of Mayo Clinic Cancer Center.
Mayo Clin Proc. 2007 Apr;82(4):490-513.

Reprogramming metastatic tumour cells with embryonic
microenvironments.
Hendrix MJ, Seftor EA, Seftor RE, Kasemeier-Kulesa J, Kulesa PM,
Postovit LM.
Nat Rev Cancer. 2007 Apr;7(4):246-55.

Targeting Nodal in malignant melanoma cells.
Postovit LM, Seftor EA, Seftor RE, Hendrix MJ.
Expert Opin Ther Targets. 2007 Apr;11(4):497-505.

Epigenetic events in malignant melanoma.
Rothhammer T, Bosserhoff AK.
Pigment Cell Res. 2007 Apr;20(2):92-111.

Molecular markers of circulating melanoma cells.
Medic S, Pearce RL, Heenan PJ, Ziman M.
Pigment Cell Res. 2007 Apr;20(2):80-91.




(contact at InTextoResearch: Marc Lacroix, Baelen, Wallonia, Belgium -
scimedweb@xxxxxxxx)

.